New shot could tame lupus kidney Flare-Ups
NCT ID NCT07229742
First seen Nov 17, 2025 · Last updated May 19, 2026 · Updated 21 times
Summary
This study tests an experimental drug called SHR-2173 for people with active lupus nephritis, a serious kidney complication of lupus. About 51 adults will receive either the drug or a placebo to see if it reduces protein in the urine, a sign of kidney damage. The goal is to control the disease and improve kidney function, not to cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTIVE LUPUS NEPHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The General Hospital of the Eastern Theater Command of the People's Liberation Army of China
RECRUITINGNanjing, Jiangsu, 210002, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.